(Q34688636)

3 August 2017

title

A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1017/S0033291700006632

2 April 2023

author name string

I. Falloon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A345313

2 April 2023

D. C. Watt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A345313

2 April 2023

M. Shepherd

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A345313

2 April 2023

language of work or name

English

0 references

publication date

1 February 1978

1 reference

full work available at URL

3 August 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0033291700006632

1 reference

DOI

https://api.crossref.org/works/10.1017/S0033291700006632

2 April 2023

published in

Psychological Medicine

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

59-70

1 reference

Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Postpsychotic depression in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Influence of selection of patients on results of clinical trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Observations on the Dose Regime of Fluphenazine Decanoate in Maintenance Therapy of Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

https://api.crossref.org/works/10.1017%2FS0033291700006632

1 reference

7 January 2021

Side effects of depot fluphenazines

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine Injection

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Trial of Maintenance Therapy in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Controlled Trial of Depot Fluphenazine in Out-patient Schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Why do schizophrenic patients refuse to take their drugs?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Schizophrenia succeeded by affective illness: catamnestic study and statistical enquiry

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Therapeutic approaches to tardive dyskinesia. A review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Tardive dyskinesia treated with pimozide

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Dependence of schizophrenic patients on elderly relatives

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700006632

7 January 2021

Long-acting tranquillizers

29

1 reference

DOI

https://api.crossref.org/works/10.1017/S0033291700006632

2 April 2023

Identifiers

DOI

0 references

1 reference